Wednesday November 26, 2014   
Find us Facebook Follow us on Twitter Watch us on YouTube    
Donate Now
  Search
  
Research Grants

Glioma Cell Migration and Invasion
Led by Steven Rosenfeld, MD, PhD at New York-Presbyterian Hospital/Columbia University Medical Center

Patients diagnosed with glioblastoma that receive treatment with anti-angiogenic medications have enjoyed a longer life expectancy than those receiving other treatments. Despite this benefit, in about 50% of patients, the tumors change from local to diffused, highly-invasive, chemotherapy-resistant and fatal. Dr. Rosenfeld will use mice to study why this change happens and how to potentially block it.

Rosenfeld is on VABC’s Medical Advisory Board.

 
Click here for a full list of research grants funded by Voices Against Brain Cancer.

 

 
Voices Against Brain Cancer is a not-for-profit public charity recognized by the IRS under 501 (c) (3)